212 related articles for article (PubMed ID: 28604454)
41. Adjuvant Therapy Use and Survival in Stage II Endometrial Cancer.
Lester-Coll NH; Young MR; Park HS; Ratner ES; Litkouhi B; Damast S
Int J Gynecol Cancer; 2017 Nov; 27(9):1904-1911. PubMed ID: 28763364
[TBL] [Abstract][Full Text] [Related]
42. Pretreatment thrombocytosis predict poor prognosis in patients with endometrial carcinoma: a systematic review and meta-analysis.
Nie D; Yang E; Li Z
BMC Cancer; 2019 Jan; 19(1):73. PubMed ID: 30646853
[TBL] [Abstract][Full Text] [Related]
43. Intravaginal brachytherapy alone for intermediate-risk endometrial cancer.
Alektiar KM; Venkatraman E; Chi DS; Barakat RR
Int J Radiat Oncol Biol Phys; 2005 May; 62(1):111-7. PubMed ID: 15850910
[TBL] [Abstract][Full Text] [Related]
44. Tumor size: a better independent predictor of distant failure and death than depth of myometrial invasion in International Federation of Gynecology and Obstetrics stage I endometrioid endometrial cancer.
Chattopadhyay S; Cross P; Nayar A; Galaal K; Naik R
Int J Gynecol Cancer; 2013 May; 23(4):690-7. PubMed ID: 23518862
[TBL] [Abstract][Full Text] [Related]
45. The clinical significance of lymphovascular space invasion in patients with low-risk endometrial cancer.
Çakır İ; Gülseren V; Büyüktalancı E; Çakır ZE; Özer M; Ata C; Sancı M; Gökçü M; Erkılınç S; Güngördük K
Rev Assoc Med Bras (1992); 2023; 69(7):e20221730. PubMed ID: 37466592
[TBL] [Abstract][Full Text] [Related]
46. Survival impact based on the thoroughness of pelvic lymphadenectomy in intermediate- or high-risk groups of endometrioid-type endometrial cancer: A multi-center retrospective cohort analysis.
Kim TH; Kim HS; Kim TJ; Chang SJ; Kim DY; Ryu SY; Kim BG; Kim YT; Bae DS; Ryu HS; Nam JH
Gynecol Oncol; 2016 Jun; 141(3):440-446. PubMed ID: 27020700
[TBL] [Abstract][Full Text] [Related]
47. Significance of monocyte counts on tumor characteristics and survival outcome of women with endometrial cancer.
Matsuo K; Hom MS; Moeini A; Machida H; Takeshima N; Roman LD; Sood AK
Gynecol Oncol; 2015 Aug; 138(2):332-8. PubMed ID: 26013698
[TBL] [Abstract][Full Text] [Related]
48. Preoperative Circulating Lymphocyte and Monocyte Counts Correlate with Patient Outcomes in Type I and Type II Endometrial Cancer.
Burgess B; Levine B; Taylor RN; Kelly MG
Reprod Sci; 2020 Jan; 27(1):194-203. PubMed ID: 32046381
[TBL] [Abstract][Full Text] [Related]
49. Significance of Monocyte Counts at Recurrence on Survival Outcome of Women With Endometrial Cancer.
Machida H; De Zoysa MY; Takiuchi T; Hom MS; Tierney KE; Matsuo K
Int J Gynecol Cancer; 2017 Feb; 27(2):302-310. PubMed ID: 27922978
[TBL] [Abstract][Full Text] [Related]
50. Ovarian preservation in young women with endometrial cancer of endometrioid histology.
Kinjyo Y; Kudaka W; Ooyama T; Inamine M; Nagai Y; Aoki Y
Acta Obstet Gynecol Scand; 2015 Apr; 94(4):430-4. PubMed ID: 25603833
[TBL] [Abstract][Full Text] [Related]
51. Preoperative Risk Stratification of Endometrial Carcinoma: L1CAM as a Biomarker.
Pasanen A; Loukovaara M; Tuomi T; Bützow R
Int J Gynecol Cancer; 2017 Sep; 27(7):1318-1324. PubMed ID: 29059097
[TBL] [Abstract][Full Text] [Related]
52. Pretreatment platelet and hemoglobin levels are neither predictive nor prognostic variables for patients with locally advanced cervical cancer treated with neoadjuvant chemotherapy and radical hysterectomy: a retrospective Italian study.
Gadducci A; Cosio S; Zola P; Tisi G; Ferrero A; Piovano E; Cristofani R; Greco C; Sartori E
Int J Gynecol Cancer; 2010 Nov; 20(8):1399-404. PubMed ID: 21051984
[TBL] [Abstract][Full Text] [Related]
53. Prognostic significance of preoperative plasma fibrinogen in endometrial cancer.
Ghezzi F; Cromi A; Siesto G; Giudici S; Serati M; Formenti G; Franchi M
Gynecol Oncol; 2010 Nov; 119(2):309-13. PubMed ID: 20688365
[TBL] [Abstract][Full Text] [Related]
54. Predictors of final histology in patients with endometrial cancer.
Frumovitz M; Singh DK; Meyer L; Smith DH; Wertheim I; Resnik E; Bodurka DC
Gynecol Oncol; 2004 Dec; 95(3):463-8. PubMed ID: 15581947
[TBL] [Abstract][Full Text] [Related]
55. Lymphovascular space invasion and cervical stromal invasion are independent risk factors for nodal metastasis in endometrioid endometrial cancer.
Solmaz U; Mat E; Dereli M; Turan V; Gungorduk K; Hasdemir P; Tosun G; Dogan A; Ozdemir A; Adiyeke M; Sanci M
Aust N Z J Obstet Gynaecol; 2015 Feb; 55(1):81-6. PubMed ID: 25688821
[TBL] [Abstract][Full Text] [Related]
56. Thrombocytosis as a prognostic factor in endometrial carcinoma.
Gücer F; Moser F; Tamussino K; Reich O; Haas J; Arikan G; Petru E; Winter R
Gynecol Oncol; 1998 Aug; 70(2):210-4. PubMed ID: 9740692
[TBL] [Abstract][Full Text] [Related]
57. Pelvic lymph node count is an important prognostic variable for FIGO stage I and II endometrial carcinoma with high-risk histology.
Lutman CV; Havrilesky LJ; Cragun JM; Secord AA; Calingaert B; Berchuck A; Clarke-Pearson DL; Soper JT
Gynecol Oncol; 2006 Jul; 102(1):92-7. PubMed ID: 16406063
[TBL] [Abstract][Full Text] [Related]
58. Positive peritoneal cytology is highly predictive of prognosis and relapse patterns in stage III (FIGO 2009) endometrial cancer.
Milgrom SA; Kollmeier MA; Abu-Rustum NR; Makker V; Gardner GJ; Barakat RR; Alektiar KM
Gynecol Oncol; 2013 Jul; 130(1):49-53. PubMed ID: 23603151
[TBL] [Abstract][Full Text] [Related]
59. Preoperative Anemia as a Prognostic Factor in Endometrioid-Type Endometrial Carcinoma.
Abu-Zaid A; Alsabban M; Abuzaid M; Alomar O; Salem H; Al-Badawi IA
J Obstet Gynaecol Can; 2018 Nov; 40(11):1393-1400. PubMed ID: 30473117
[TBL] [Abstract][Full Text] [Related]
60. The association of pretreatment thrombocytosis with prognosis and clinicopathological significance in cervical cancer: a systematic review and meta-analysis.
Cheng J; Zeng Z; Ye Q; Zhang Y; Yan R; Liang C; Wang J; Li M; Yi M
Oncotarget; 2017 Apr; 8(15):24327-24336. PubMed ID: 28212582
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
